Melbourne buyout firm Advent Partners has sold Flintfox, a fast-growing pricing and rebate platform, to San Francisco’s Enable, after four years of investment pushed revenues 160 per cent higher.

CRISPR-Cas9 is one of the biggest discoveries of the 21st century. Since it was developed in 2012, this gene-editing tool has revolutionized biology research, making it easier to study disease and ...